Titre : Agents séquestrants

Agents séquestrants : Questions médicales fréquentes

Termes MeSH sélectionnés :

Language Disorders

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment diagnostiquer une intoxication aux métaux lourds ?

Des tests sanguins et urinaires peuvent détecter la présence de métaux lourds.
Intoxication aux métaux Tests de laboratoire
#2

Quels examens pour évaluer l'efficacité d'un agent séquestrant ?

Des analyses biochimiques peuvent mesurer les niveaux de nutriments ou toxines.
Évaluation de traitement Biochimie clinique
#3

Quels symptômes indiquent un besoin d'agents séquestrants ?

Des symptômes comme des douleurs abdominales ou des troubles digestifs peuvent indiquer un besoin.
Symptômes digestifs Troubles gastro-intestinaux
#4

Comment identifier une carence nutritionnelle ?

Des tests sanguins peuvent révéler des carences en vitamines ou minéraux.
Carence nutritionnelle Tests sanguins
#5

Quels signes d'overdose d'agents séquestrants ?

Des nausées, vomissements ou diarrhées peuvent signaler une overdose.
Overdose Effets indésirables

Symptômes 5

#1

Quels symptômes d'une carence en fer ?

Fatigue, pâleur, essoufflement et vertiges sont des symptômes courants.
Carence en fer Symptômes
#2

Comment reconnaître une toxicité au plomb ?

Des douleurs abdominales, des troubles neurologiques et des anémies peuvent survenir.
Toxicité au plomb Symptômes neurologiques
#3

Quels signes d'une carence en calcium ?

Des crampes musculaires, des engourdissements et des troubles de l'humeur peuvent apparaître.
Carence en calcium Symptômes musculaires
#4

Quels symptômes d'une intoxication au mercure ?

Des tremblements, des troubles de la mémoire et des problèmes de vision peuvent se manifester.
Intoxication au mercure Symptômes neurologiques
#5

Comment se manifeste une carence en potassium ?

Des faiblesses musculaires, des palpitations et des troubles du rythme cardiaque peuvent survenir.
Carence en potassium Symptômes cardiaques

Prévention 5

#1

Comment prévenir les carences nutritionnelles ?

Une alimentation équilibrée et variée est essentielle pour éviter les carences.
Prévention des carences Nutrition
#2

Quelles mesures pour éviter l'exposition aux métaux lourds ?

Éviter les aliments contaminés et utiliser des filtres à eau peut réduire l'exposition.
Exposition aux métaux Prévention
#3

Comment réduire le cholestérol par l'alimentation ?

Consommer des fibres solubles et limiter les graisses saturées aide à réduire le cholestérol.
Cholestérol Régime alimentaire
#4

Quels aliments riches en calcium pour la prévention ?

Les produits laitiers, les légumes verts et les noix sont de bonnes sources de calcium.
Calcium Alimentation
#5

Comment éviter les effets secondaires des séquestrants ?

Prendre les agents séquestrants avec suffisamment d'eau et suivre les recommandations médicales.
Effets indésirables Conseils médicaux

Traitements 5

#1

Quels agents séquestrants pour le cholestérol ?

Les résines comme le cholestyramine sont utilisées pour réduire le cholestérol sanguin.
Cholestérol Résines
#2

Comment fonctionnent les agents séquestrants ?

Ils se lient aux substances dans l'intestin, empêchant leur absorption dans le sang.
Mécanisme d'action Absorption intestinale
#3

Quels sont les effets secondaires des agents séquestrants ?

Des effets comme des ballonnements, des nausées et des troubles digestifs peuvent survenir.
Effets indésirables Troubles gastro-intestinaux
#4

Comment administrer un agent séquestrant ?

Ils sont généralement pris par voie orale, souvent mélangés à des liquides.
Administration orale Formes pharmaceutiques
#5

Quels agents séquestrants pour les métaux lourds ?

Des agents comme l'EDTA sont utilisés pour traiter les intoxications aux métaux lourds.
Intoxication aux métaux EDTA

Complications 5

#1

Quelles complications d'une surconsommation d'agents séquestrants ?

Une surconsommation peut entraîner des carences nutritionnelles et des troubles digestifs.
Surconsommation Complications
#2

Quels risques d'une utilisation prolongée ?

Une utilisation prolongée peut causer des déséquilibres électrolytiques et des carences.
Utilisation prolongée Déséquilibres électrolytiques
#3

Comment les agents séquestrants affectent-ils l'absorption des médicaments ?

Ils peuvent réduire l'absorption de certains médicaments, diminuant leur efficacité.
Interactions médicamenteuses Absorption
#4

Quelles complications liées à l'intoxication au plomb ?

Des complications neurologiques, rénales et cardiovasculaires peuvent survenir.
Intoxication au plomb Complications
#5

Quels effets à long terme des agents séquestrants ?

Des effets à long terme peuvent inclure des carences nutritionnelles et des troubles métaboliques.
Effets à long terme Troubles métaboliques

Facteurs de risque 5

#1

Quels facteurs augmentent le risque de carences ?

Une alimentation déséquilibrée, des maladies chroniques et des régimes restrictifs augmentent le risque.
Facteurs de risque Carences nutritionnelles
#2

Qui est à risque d'intoxication au mercure ?

Les personnes consommant régulièrement des poissons contaminés sont à risque élevé.
Intoxication au mercure Risque alimentaire
#3

Quels groupes sont vulnérables aux carences en calcium ?

Les personnes âgées, les femmes enceintes et les végétariens peuvent être plus vulnérables.
Carence en calcium Groupes vulnérables
#4

Quels comportements augmentent le risque d'intoxication aux métaux ?

Travailler dans des environnements contaminés ou utiliser des produits non réglementés augmente le risque.
Intoxication aux métaux Comportements à risque
#5

Quels facteurs influencent l'absorption des nutriments ?

L'âge, la santé digestive et les interactions médicamenteuses influencent l'absorption.
Absorption des nutriments Facteurs influents
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Agents séquestrants : Questions médicales les plus fréquentes", "headline": "Agents séquestrants : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Agents séquestrants : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-03", "dateModified": "2025-04-28", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Agents séquestrants" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Utilisations spécialisées de produits chimiques", "url": "https://questionsmedicales.fr/mesh/D020313", "about": { "@type": "MedicalCondition", "name": "Utilisations spécialisées de produits chimiques", "code": { "@type": "MedicalCode", "code": "D020313", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Chélateurs", "alternateName": "Chelating Agents", "url": "https://questionsmedicales.fr/mesh/D002614", "about": { "@type": "MedicalCondition", "name": "Chélateurs", "code": { "@type": "MedicalCode", "code": "D002614", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.832.500" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Agents chélateurs du calcium", "alternateName": "Calcium Chelating Agents", "url": "https://questionsmedicales.fr/mesh/D065096", "about": { "@type": "MedicalCondition", "name": "Agents chélateurs du calcium", "code": { "@type": "MedicalCode", "code": "D065096", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.832.500.204" } } }, { "@type": "MedicalWebPage", "name": "Agents chélateurs du fer", "alternateName": "Iron Chelating Agents", "url": "https://questionsmedicales.fr/mesh/D007502", "about": { "@type": "MedicalCondition", "name": "Agents chélateurs du fer", "code": { "@type": "MedicalCode", "code": "D007502", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.832.500.410" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Sidérophores", "alternateName": "Siderophores", "url": "https://questionsmedicales.fr/mesh/D017262", "about": { "@type": "MedicalCondition", "name": "Sidérophores", "code": { "@type": "MedicalCode", "code": "D017262", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.832.500.410.750" } } } ] }, { "@type": "MedicalWebPage", "name": "Sidérophores", "alternateName": "Siderophores", "url": "https://questionsmedicales.fr/mesh/D017262", "about": { "@type": "MedicalCondition", "name": "Sidérophores", "code": { "@type": "MedicalCode", "code": "D017262", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.832.500.410.750" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Agents séquestrants", "alternateName": "Sequestering Agents", "code": { "@type": "MedicalCode", "code": "D064449", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Xueli Cao", "url": "https://questionsmedicales.fr/author/Xueli%20Cao", "affiliation": { "@type": "Organization", "name": "Beijing Advanced Innovation Center for Soft Matter Science and Engineering, State Key Laboratory of Chemical Resource Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China." } }, { "@type": "Person", "name": "Yu Xiao", "url": "https://questionsmedicales.fr/author/Yu%20Xiao", "affiliation": { "@type": "Organization", "name": "Ministry of Education Key Laboratory of Protein Science, Beijing Advanced Innovation Center for Structural Biology, Beijing Frontier Research Center for Biological Structure, School of Life Sciences, Tsinghua University, Tsinghua-Peking Center for Life Sciences, Beijing 100084, China." } }, { "@type": "Person", "name": "Erin Huiting", "url": "https://questionsmedicales.fr/author/Erin%20Huiting", "affiliation": { "@type": "Organization", "name": "Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94158, USA." } }, { "@type": "Person", "name": "Dong Li", "url": "https://questionsmedicales.fr/author/Dong%20Li", "affiliation": { "@type": "Organization", "name": "Beijing Advanced Innovation Center for Soft Matter Science and Engineering, State Key Laboratory of Chemical Resource Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China." } }, { "@type": "Person", "name": "Jie Ren", "url": "https://questionsmedicales.fr/author/Jie%20Ren", "affiliation": { "@type": "Organization", "name": "State Key Laboratory for Biology of Plant Diseases and Insect Pests, Ministry of Agriculture, Institute of Plant Protection, Chinese Academy of Agricultural Sciences, Beijing 100081, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Language disorders in patients with striatal lesions: Deciphering the role of the striatum in language performance.", "datePublished": "2023-06-01", "url": "https://questionsmedicales.fr/article/37354871", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.cortex.2023.04.016" } }, { "@type": "ScholarlyArticle", "name": "Access to Speech and Language Services and Service Providers for Children With Speech and Language Disorders.", "datePublished": "2022-05-25", "url": "https://questionsmedicales.fr/article/35613324", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1044/2022_AJSLP-21-00287" } }, { "@type": "ScholarlyArticle", "name": "Therapeutic hypnosis in a child with a written language disorder.", "datePublished": "2022-10-05", "url": "https://questionsmedicales.fr/article/36197740", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/00029157.2022.2108746" } }, { "@type": "ScholarlyArticle", "name": "Telepractice in the diagnosis and treatment of pediatric speech-language disorders: The opinions and experiences of speech-language pathologists.", "datePublished": "2023-04-19", "url": "https://questionsmedicales.fr/article/37116275", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ijporl.2023.111560" } }, { "@type": "ScholarlyArticle", "name": "Activities and participation of children with language disorders in outpatient care according to the ICF.", "datePublished": "2023-08-04", "url": "https://questionsmedicales.fr/article/37556703", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1590/2317-1782/20232022007pt" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Actions chimiques et utilisations", "item": "https://questionsmedicales.fr/mesh/D020164" }, { "@type": "ListItem", "position": 3, "name": "Utilisations spécialisées de produits chimiques", "item": "https://questionsmedicales.fr/mesh/D020313" }, { "@type": "ListItem", "position": 4, "name": "Agents séquestrants", "item": "https://questionsmedicales.fr/mesh/D064449" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Agents séquestrants - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Agents séquestrants", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-15", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Agents séquestrants", "description": "Comment diagnostiquer une intoxication aux métaux lourds ?\nQuels examens pour évaluer l'efficacité d'un agent séquestrant ?\nQuels symptômes indiquent un besoin d'agents séquestrants ?\nComment identifier une carence nutritionnelle ?\nQuels signes d'overdose d'agents séquestrants ?", "url": "https://questionsmedicales.fr/mesh/D064449?mesh_terms=Language+Disorders#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Agents séquestrants", "description": "Quels symptômes d'une carence en fer ?\nComment reconnaître une toxicité au plomb ?\nQuels signes d'une carence en calcium ?\nQuels symptômes d'une intoxication au mercure ?\nComment se manifeste une carence en potassium ?", "url": "https://questionsmedicales.fr/mesh/D064449?mesh_terms=Language+Disorders#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Agents séquestrants", "description": "Comment prévenir les carences nutritionnelles ?\nQuelles mesures pour éviter l'exposition aux métaux lourds ?\nComment réduire le cholestérol par l'alimentation ?\nQuels aliments riches en calcium pour la prévention ?\nComment éviter les effets secondaires des séquestrants ?", "url": "https://questionsmedicales.fr/mesh/D064449?mesh_terms=Language+Disorders#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Agents séquestrants", "description": "Quels agents séquestrants pour le cholestérol ?\nComment fonctionnent les agents séquestrants ?\nQuels sont les effets secondaires des agents séquestrants ?\nComment administrer un agent séquestrant ?\nQuels agents séquestrants pour les métaux lourds ?", "url": "https://questionsmedicales.fr/mesh/D064449?mesh_terms=Language+Disorders#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Agents séquestrants", "description": "Quelles complications d'une surconsommation d'agents séquestrants ?\nQuels risques d'une utilisation prolongée ?\nComment les agents séquestrants affectent-ils l'absorption des médicaments ?\nQuelles complications liées à l'intoxication au plomb ?\nQuels effets à long terme des agents séquestrants ?", "url": "https://questionsmedicales.fr/mesh/D064449?mesh_terms=Language+Disorders#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Agents séquestrants", "description": "Quels facteurs augmentent le risque de carences ?\nQui est à risque d'intoxication au mercure ?\nQuels groupes sont vulnérables aux carences en calcium ?\nQuels comportements augmentent le risque d'intoxication aux métaux ?\nQuels facteurs influencent l'absorption des nutriments ?", "url": "https://questionsmedicales.fr/mesh/D064449?mesh_terms=Language+Disorders#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une intoxication aux métaux lourds ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins et urinaires peuvent détecter la présence de métaux lourds." } }, { "@type": "Question", "name": "Quels examens pour évaluer l'efficacité d'un agent séquestrant ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des analyses biochimiques peuvent mesurer les niveaux de nutriments ou toxines." } }, { "@type": "Question", "name": "Quels symptômes indiquent un besoin d'agents séquestrants ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme des douleurs abdominales ou des troubles digestifs peuvent indiquer un besoin." } }, { "@type": "Question", "name": "Comment identifier une carence nutritionnelle ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins peuvent révéler des carences en vitamines ou minéraux." } }, { "@type": "Question", "name": "Quels signes d'overdose d'agents séquestrants ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des nausées, vomissements ou diarrhées peuvent signaler une overdose." } }, { "@type": "Question", "name": "Quels symptômes d'une carence en fer ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue, pâleur, essoufflement et vertiges sont des symptômes courants." } }, { "@type": "Question", "name": "Comment reconnaître une toxicité au plomb ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs abdominales, des troubles neurologiques et des anémies peuvent survenir." } }, { "@type": "Question", "name": "Quels signes d'une carence en calcium ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des crampes musculaires, des engourdissements et des troubles de l'humeur peuvent apparaître." } }, { "@type": "Question", "name": "Quels symptômes d'une intoxication au mercure ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des tremblements, des troubles de la mémoire et des problèmes de vision peuvent se manifester." } }, { "@type": "Question", "name": "Comment se manifeste une carence en potassium ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des faiblesses musculaires, des palpitations et des troubles du rythme cardiaque peuvent survenir." } }, { "@type": "Question", "name": "Comment prévenir les carences nutritionnelles ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée et variée est essentielle pour éviter les carences." } }, { "@type": "Question", "name": "Quelles mesures pour éviter l'exposition aux métaux lourds ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les aliments contaminés et utiliser des filtres à eau peut réduire l'exposition." } }, { "@type": "Question", "name": "Comment réduire le cholestérol par l'alimentation ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Consommer des fibres solubles et limiter les graisses saturées aide à réduire le cholestérol." } }, { "@type": "Question", "name": "Quels aliments riches en calcium pour la prévention ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Les produits laitiers, les légumes verts et les noix sont de bonnes sources de calcium." } }, { "@type": "Question", "name": "Comment éviter les effets secondaires des séquestrants ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Prendre les agents séquestrants avec suffisamment d'eau et suivre les recommandations médicales." } }, { "@type": "Question", "name": "Quels agents séquestrants pour le cholestérol ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les résines comme le cholestyramine sont utilisées pour réduire le cholestérol sanguin." } }, { "@type": "Question", "name": "Comment fonctionnent les agents séquestrants ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Ils se lient aux substances dans l'intestin, empêchant leur absorption dans le sang." } }, { "@type": "Question", "name": "Quels sont les effets secondaires des agents séquestrants ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des effets comme des ballonnements, des nausées et des troubles digestifs peuvent survenir." } }, { "@type": "Question", "name": "Comment administrer un agent séquestrant ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Ils sont généralement pris par voie orale, souvent mélangés à des liquides." } }, { "@type": "Question", "name": "Quels agents séquestrants pour les métaux lourds ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des agents comme l'EDTA sont utilisés pour traiter les intoxications aux métaux lourds." } }, { "@type": "Question", "name": "Quelles complications d'une surconsommation d'agents séquestrants ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Une surconsommation peut entraîner des carences nutritionnelles et des troubles digestifs." } }, { "@type": "Question", "name": "Quels risques d'une utilisation prolongée ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Une utilisation prolongée peut causer des déséquilibres électrolytiques et des carences." } }, { "@type": "Question", "name": "Comment les agents séquestrants affectent-ils l'absorption des médicaments ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent réduire l'absorption de certains médicaments, diminuant leur efficacité." } }, { "@type": "Question", "name": "Quelles complications liées à l'intoxication au plomb ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Des complications neurologiques, rénales et cardiovasculaires peuvent survenir." } }, { "@type": "Question", "name": "Quels effets à long terme des agents séquestrants ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des effets à long terme peuvent inclure des carences nutritionnelles et des troubles métaboliques." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de carences ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation déséquilibrée, des maladies chroniques et des régimes restrictifs augmentent le risque." } }, { "@type": "Question", "name": "Qui est à risque d'intoxication au mercure ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes consommant régulièrement des poissons contaminés sont à risque élevé." } }, { "@type": "Question", "name": "Quels groupes sont vulnérables aux carences en calcium ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes âgées, les femmes enceintes et les végétariens peuvent être plus vulnérables." } }, { "@type": "Question", "name": "Quels comportements augmentent le risque d'intoxication aux métaux ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Travailler dans des environnements contaminés ou utiliser des produits non réglementés augmente le risque." } }, { "@type": "Question", "name": "Quels facteurs influencent l'absorption des nutriments ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "L'âge, la santé digestive et les interactions médicamenteuses influencent l'absorption." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 28/04/2025

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Xueli Cao

3 publications dans cette catégorie

Affiliations :
  • Beijing Advanced Innovation Center for Soft Matter Science and Engineering, State Key Laboratory of Chemical Resource Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.

Yu Xiao

3 publications dans cette catégorie

Affiliations :
  • Ministry of Education Key Laboratory of Protein Science, Beijing Advanced Innovation Center for Structural Biology, Beijing Frontier Research Center for Biological Structure, School of Life Sciences, Tsinghua University, Tsinghua-Peking Center for Life Sciences, Beijing 100084, China.

Erin Huiting

3 publications dans cette catégorie

Affiliations :
  • Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94158, USA.

Dong Li

3 publications dans cette catégorie

Affiliations :
  • Beijing Advanced Innovation Center for Soft Matter Science and Engineering, State Key Laboratory of Chemical Resource Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.

Jie Ren

3 publications dans cette catégorie

Affiliations :
  • State Key Laboratory for Biology of Plant Diseases and Insect Pests, Ministry of Agriculture, Institute of Plant Protection, Chinese Academy of Agricultural Sciences, Beijing 100081, China.

Yu Wang

3 publications dans cette catégorie

Affiliations :
  • Beijing Advanced Innovation Center for Soft Matter Science and Engineering, State Key Laboratory of Chemical Resource Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.

Joseph Bondy-Denomy

3 publications dans cette catégorie

Affiliations :
  • Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94158, USA; Quantitative Biosciences Institute, University of California, San Francisco, San Francisco, CA 94158, USA; Innovative Genomics Institute, Berkeley, CA 94720, USA. Electronic address: joseph.bondy-denomy@ucsf.edu.

Yue Feng

3 publications dans cette catégorie

Affiliations :
  • Beijing Advanced Innovation Center for Soft Matter Science and Engineering, State Key Laboratory of Chemical Resource Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China. Electronic address: fengyue@mail.buct.edu.cn.

Beob Gyun Kim

2 publications dans cette catégorie

Affiliations :
  • Department of Animal Science and Technology, Konkuk University, Seoul 05029, Korea.

Christian Hoffmann

2 publications dans cette catégorie

Affiliations :
  • Laboratory of Molecular Neuroscience, German Center for Neurodegenerative Diseases (DZNE), 10117, Berlin, Germany.
Publications dans "Agents séquestrants" :

Franziska Trnka

2 publications dans cette catégorie

Affiliations :
  • Laboratory of Molecular Neuroscience, German Center for Neurodegenerative Diseases (DZNE), 10117, Berlin, Germany.
Publications dans "Agents séquestrants" :

Dragomir Milovanovic

2 publications dans cette catégorie

Affiliations :
  • Laboratory of Molecular Neuroscience, German Center for Neurodegenerative Diseases (DZNE), 10117, Berlin, Germany. dragomir.milovanovic@dzne.de.
Publications dans "Agents séquestrants" :

Takeaki Ozawa

2 publications dans cette catégorie

Affiliations :
  • Department of Chemistry, School of Science, The University of Tokyo, Tokyo, Japan. ozawa@chem.s.u-tokyo.ac.jp.

Yi Zhang

2 publications dans cette catégorie

Affiliations :
  • ABLife BioBigData Institute, Wuhan, Hubei, China. yizhang@ablife.cc.
  • Center for Genome Analysis, ABLife Inc., Wuhan, Hubei, China. yizhang@ablife.cc.
Publications dans "Agents séquestrants" :

Xujun Cao

2 publications dans cette catégorie

Affiliations :
  • Department of Chemistry, Stanford University, Stanford, CA 94305, USA; Department of Biochemistry, Stanford University, Stanford, CA 94305, USA; Sarafan ChEM-H Institute, Stanford University, Stanford, CA 94305, USA; Arc Institute, Palo Alto, CA 94304, USA.

Iana Fedorova

2 publications dans cette catégorie

Affiliations :
  • Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94158, USA.
Publications dans "Agents séquestrants" :

Linlin Guan

2 publications dans cette catégorie

Affiliations :
  • Beijing Advanced Innovation Center for Soft Matter Science and Engineering, State Key Laboratory of Chemical Resource Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.

Lingyin Li

2 publications dans cette catégorie

Affiliations :
  • Department of Biochemistry, Stanford University, Stanford, CA 94305, USA; Sarafan ChEM-H Institute, Stanford University, Stanford, CA 94305, USA; Arc Institute, Palo Alto, CA 94304, USA.

Yan Wu

1 publication dans cette catégorie

Affiliations :
  • Department of Chemistry, Shanghai Key Laboratory of Molecular Catalysis and Innovative Materials, Fudan University Shanghai 200438 China zhouw@fudan.edu.cn zhangdw@fudan.edu.cn ztli@fudan.edu.cn.
Publications dans "Agents séquestrants" :

Yue-Yang Liu

1 publication dans cette catégorie

Affiliations :
  • Department of Chemistry, Shanghai Key Laboratory of Molecular Catalysis and Innovative Materials, Fudan University Shanghai 200438 China zhouw@fudan.edu.cn zhangdw@fudan.edu.cn ztli@fudan.edu.cn.
Publications dans "Agents séquestrants" :

Sources (10000 au total)

Access to Speech and Language Services and Service Providers for Children With Speech and Language Disorders.

The purposes of this study were to (a) examine children's access to services for their speech and language disorders during their lifetimes; (b) identify any child, disorder, and family characteristic... Data from the 2012 National Health Interview Survey were used for this retrospective cohort study. Our sample included 491 children (ages 3;0-17;11 [years;months]) with speech disorders and 333 childr... Approximately 75% of children with speech and language disorders had ever received services for their difficulties. Privately insured children and children with co-occurring conditions were more likel... Most children with speech and language disorders received services. However, disparities existed by race/ethnicity, health insurance type, co-occurring diagnoses, and disorder duration (speech only). ... https://doi.org/10.23641/asha.19799389....

Telepractice in the diagnosis and treatment of pediatric speech-language disorders: The opinions and experiences of speech-language pathologists.

This prospective cross-sectional study aimed to investigate the opinions and experiences with telepractice (TP) of Dutch-speaking speech-language pathologists (SLPs) living in the Dutch-speaking part ... Twenty-nine Dutch-speaking speech-language pathologists living in Flanders (age category 20-30 years: n = 16/29, 55.2%, 31-40 years: n = 10/29, 34.2%, 41-50 years: n = 2/29, 6.9%, 51-60 years: n = 1/2... The study showed a statistically significant association between years of clinical experience of SLPs and their opinion that TP does not provide more options in a clinical setting compared to face-to-... Expertise in multiple domains of pediatric speech-language therapy resulted in experiencing more added value of TP during the corona pandemic, possibly because of the experience of multiple different ...

Activities and participation of children with language disorders in outpatient care according to the ICF.

To identify the main categories of the Activities and Participation component of the International Classification of Functioning, Disability, and Health and to verify the association with age, gender,... This is an analytical and cross-sectional observational study, carried out with secondary data from 32 medical records of children with the majority male, mean age of 41.03 months, in early childhood ... The descriptive analysis of the pre-selected categories allowed us to verify a high number of "Not informed" answers, with a higher percentage in vocal expression without speech (d331) performance (93... Difficulties were identified in several categories of the Activities and Participation component and statistically significant associations between them and sociodemographic data and speech therapy di...

The Relationship Between Speech and Language Disorders and Working Memory: Children with Attention Deficit and Hyperactivity Disorder and Typical Development.

To examine the speech, language, and communication skills of school-age children with attention deficit and hyperactive disorder.... The sample of the study consists of attention deficit and hyperactivity disorder (... SPSS program was used in the analysis of the data. Mann Whitney... It has been concluded that language, speech, and working memory skills of children with attention deficit and hyperactivity disorder are lower than their peers with typical development. Speech and lan...

Distinct reinforcement learning profiles distinguish between language and attentional neurodevelopmental disorders.

Theoretical models posit abnormalities in cortico-striatal pathways in two of the most common neurodevelopmental disorders (Developmental dyslexia, DD, and Attention deficit hyperactive disorder, ADHD... Our results show that, relative to neurotypicals, DD individuals showed an impairment in model-free but not in model-based learning, whereas in ADHD the ability to use both model-free and model-based ... Thus, learning impairments in DD may be linked to a selective deficit in the ability to form action-outcome associations based on previous history, whereas in ADHD some learning deficits may be relate...

Language disorder and internalizing mental health problems in youth offenders: A systematic review.

The prevalence of language disorder in youth offenders far exceeds rates reported in community samples. Youth involved in the justice system are also at increased risk of a range of psychiatric disord... To explore the co-occurrence of language disorder and anxiety and depression in youth offenders.... A systematic literature search of six databases (CINAHL, ERIC, Medline, PyscINFO, PubMED, Scopus) was conducted (September 2021) using key search terms relevant to the systematic review question. Stud... Eight studies met the eligibility criteria. A range of measures was used to assess language abilities across samples. Only two studies directly addressed the relationship between language disorder and... Although the results did not support a significant relationship between language disorder and internalizing mental health problems in youth offenders, the two appear to occur comorbidly as evidenced b... What is already known on this subject The markedly high rates of language disorder in youth involved in the justice system have been widely reported. It is also known that externalizing mental health ...

ICF and perception of functioning according to children/adolescents in follow-up with speech/language disorders.

To characterize changes in the functioning aspects, in the perception of children and adolescents with speech and language disorders under speech-language follow-up, using the ICF.... Descriptive, analytical and longitudinal research, with a qualitative and quantitative approach, whose sample consisted of 60 children and adolescents: 30 with speech and language disorders and 30 wit... The use of ICF allowed characterizing changes resulting from speech-language follow-up. Participants with speech and language disorders presented a decrease in the magnitude of the qualifiers in the c... The findings show changes in components of Body Functions, Activities and Participation, and the influence of Environmental Factors after speech-language follow-up, in the perception of the studied gr...

Association between exposure to antibiotics during pregnancy or early infancy and risk of autism spectrum disorder, intellectual disorder, language disorder, and epilepsy in children: population based cohort study.

To evaluate the association between antibiotic use during pregnancy or early infancy and the risk of neurodevelopmental disorders in children.... Nationwide population based cohort study and sibling analysis.... Korea's National Health Insurance Service mother-child linked database, 2008-21.... All children live born between 2009 and 2020, followed up until 2021 to compare those with and without antibiotic exposure during pregnancy or early infancy (first six months of life).... Autism spectrum disorder, intellectual disorder, language disorder, and epilepsy in children. After 1:1 propensity score matching based on many potential confounders, hazard ratios with 95% confidence... After propensity score matching, 1 961 744 children were identified for the pregnancy analysis and 1 609 774 children were identified for the early infancy analysis. Although antibiotic exposure durin... In this large cohort study, antibiotic exposure during pregnancy or early infancy was not associated with an increased risk of autism spectrum disorder, intellectual disorder, or language disorder in ...